Clinical Trials Directory

Trials / Completed

CompletedNCT01612598

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Feasibility of a Palliative Care Intervention for Patients on Phase 1 Clinical Trials

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Patients enrolled in phase I clinical trials could potentially benefit from palliative care concurrently, yet limited evidence is available to support such a change in care. The primary purpose of this study is to test the feasibility of a palliative care intervention (PCI) for patients participating in a phase I therapeutic clinical trial

Detailed description

PRIMARY OBJECTIVES: I. Describe the feasibility of implementing a PCI for patients on phase I clinical trials (study accrual and retention). II. Describe the initial impact of a PCI on key patient outcome measures (quality of life \[QOL\], psychological distress, satisfaction with communication, symptom intensity, symptom distress, and patient satisfaction) over time. OUTLINE: PCI PART I: Patients undergo comprehensive palliative care (PC) assessment based on baseline data and complete goals of care discussion. PCI PART II: Following the first dose of phase I investigational treatment, patients meet with the interdisciplinary team (IDT), where PC recommendations are made. This is followed by two patient educational sessions that will cover QOL-related domains, including physical, social, emotional, and spiritual well-being. Supportive care referrals are made based on IDT recommendations.

Conditions

Interventions

TypeNameDescription
OTHERcounseling interventionUndergo PCI
PROCEDUREquality-of-life assessmentAncillary studies
OTHERquestionnaire administrationAncillary studies
OTHEReducational interventionUndergo PCI

Timeline

Start date
2012-07-01
Primary completion
2013-06-01
Completion
2014-01-01
First posted
2012-06-06
Last updated
2014-01-31

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01612598. Inclusion in this directory is not an endorsement.